VivoSeq
Other

Surgical Site Infections

0

Pipeline Programs

1

Active Trials

1

Companies Involved

Surgical Site Infections is an early-stage landscape with 0 programs across 1 company. The most active players are Menarini.

Pipeline Metrics

Competitive Density

6/100

Pipeline Velocity

0/100

Mech. Concentration

N/A

Completion Rate

80/100

Attrition Rate

16/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

19

clinical trials

Completed12 · 63%
Unknown status3 · 16%
Terminated2 · 11%
Withdrawn1 · 5%
Recruiting1 · 5%

Trial Activity

19 trials

Page 1 of 2

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)